Trade RCKTW anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Rocket Pharmaceuticals, Inc. Warrant (RCKTW) is trading at US$0.00, up 0.00% today as of Aug 28, 11:46 EDT. Over the past 52 weeks, RCKTW has traded between US$0.00 and US$0.04. On Syfe you can trade RCKTW with $0 commission and add it to your watchlist.
| Previous close | US$0.00 |
|---|---|
| 52-week range | US$0.00 – US$0.04 |
| Volume | 1K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Rocket Pharmaceuticals, Inc. Warrant
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. The firm's multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.
Year: 2023
Rocket Pharmaceuticals, Inc. Warrant (RCKTW) stock is trading at US$0.00, 0.00% from the previous close of US$0.00.
The 52-week high for Rocket Pharmaceuticals, Inc. Warrant (RCKTW) stock is US$0.04.
The 52-week low for Rocket Pharmaceuticals, Inc. Warrant (RCKTW) stock is US$0.00.
Rocket Pharmaceuticals, Inc. Warrant (RCKTW) does not currently pay a dividend.
Stay on top of RCKTW
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
